The new chip enables the firm's digital PCR system to test up to 240 samples per day, and also uses lower volumes of sample input.
OmniVis is developing the assay for cholera detection in environmental samples while the lab that created it is working toward a paper-based HIV test.
New funding will support genome-wide studies to uncover loci conferring immunity to a live-attenuated Plasmodium vaccine.
The firm also continues to use its methylation-specific PCR technology to develop assays for partners in the oncology space.
New funding will support assay development and lab space to offer test services, and ultimately a test kit using the firm's resistance database.
Researchers showed that the test had equivalent results to a lab-based assay and has the potential for a faster turnaround time.
Despite a recent positive economic modeling study, the debate over appropriate use of the ME panel seems likely to continue until more outcomes studies are conducted.
The research highlighted particular challenges for gram-negative organisms among a population of higher-risk patients.
ChromaCode this week launched its first product, a research-use-only test for nine tick-borne pathogens designed for research use on any thermal cycler.
The firm is wrapping up a pre-order period and recently signed a distribution deal with D-Mark Bioscience for the new instrument, called Liberty16.
The nonprofit Biden Cancer Initiative is suspending its operations, according to the Associated Press.
Researchers examine how white nationalists handle personal genetic ancestry results that conflict with their racist worldview, the New York Times reports.
NPR speaks with research participants before and after they learn their APOE E4 status, which affects their risk of developing Alzheimer's disease.
In PLOS this week: genetic characterization of Toxoplasma gondii strains, Crimean-Congo Hemorrhagic Fever Virus uncovered in Sudan, and more.